Education
About Us
Working with TipRanks
Follow Us
Capha Pharmaceuticals Inc. (FPSUF)
OTHER OTC:FPSUF
RESEARCH TOOLSreports
FPSUF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume4.59K
Average Volume (3M)0.00
Market Cap
$64.00
Enterprise ValueN/A
Total Cash (Recent Filing)$1.38K
Total Debt (Recent Filing)$560.07K
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Dec 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding64,431,030
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
FPSUF FAQ
What was Capha Pharmaceuticals Inc.’s price range in the past 12 months?
Capha Pharmaceuticals Inc. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Capha Pharmaceuticals Inc.’s market cap?
Capha Pharmaceuticals Inc.’s market cap is $64.00.
When is Capha Pharmaceuticals Inc.’s upcoming earnings report date?
Capha Pharmaceuticals Inc.’s upcoming earnings report date is Dec 01, 2025 which is in 105 days.
How were Capha Pharmaceuticals Inc.’s earnings last quarter?
Capha Pharmaceuticals Inc. released its earnings results on Jul 31, 2025. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Capha Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Capha Pharmaceuticals Inc.’s price is currently Overvalued.
Does Capha Pharmaceuticals Inc. pay dividends?
Capha Pharmaceuticals Inc. does not currently pay dividends.
What is Capha Pharmaceuticals Inc.’s EPS estimate?
Capha Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Capha Pharmaceuticals Inc. have?
Capha Pharmaceuticals Inc. has 64,431,030 shares outstanding.
What happened to Capha Pharmaceuticals Inc.’s price movement after its last earnings report?
Capha Pharmaceuticals Inc. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Capha Pharmaceuticals Inc.?
Currently, no hedge funds are holding shares in FPSUF
Company Description
Capha Pharmaceuticals Inc.
Capha Pharmaceuticals (FPSUF) is a biopharmaceutical company that specializes in the research, development, and commercialization of innovative medicines. The company operates within the healthcare sector, focusing primarily on the creation of therapeutic solutions for unmet medical needs. Capha Pharmaceuticals is committed to advancing medical science through its cutting-edge drug development programs and collaborations with leading research institutions.